One can but admire the intricate way in which biomolecular structures are formed and cooperate to allow proper cellular function. A prominent example of such intricacy is the assembly of the five inner membrane embedded enzymatic complexes of the mitochondrial oxidative phosphorylation (OXPHOS) system, which involves the stepwise combination of N 80 subunits and prosthetic groups encoded by both the mitochondrial and nuclear genomes. This review will focus on the assembly of the most complicated OXPHOS structure: complex I (NADH: ubiquinone oxidoreductase, EC 1.6.5.3). Recent studies into complex I assembly in human cells have resulted in several models elucidating a thus far enigmatic process. In this review, special attention will be given to the overlap between the various assembly models proposed in different organisms. Complex I being a complicated structure, its assembly must be prone to some form of coordination. This is where chaperone proteins come into play, some of which may relate complex I assembly to processes such as apoptosis and even immunity.
1. Introduction
Complex I function
The cornerstone of cellular energy production is the mitochondrial oxidative phosphorylation (OXPHOS) system. It produces energy via the concerted action of five membrane embedded enzyme complexes, ultimately coupling oxidation of substrate molecules NADH and FADH 2 to phosphorylation of ADP to ATP. The largest of the five OXPHOS complexes is complex I (NADH:ubiquinone oxidoreductase; EC 1.6.5.3; hereafter referred to as CI). This complex binds and oxidizes NADH to free electrons via a noncovalently bound flavine mononucleotide (FMN). The electrons are subsequently transferred via a cascade of up to nine iron-sulfur clusters to electron acceptor ubiquinone and then through the OXPHOS system to reduce molecular oxygen at complex IV. The energy released during this process is used to drive proton translocation across the mitochondrial inner membrane. Hence, together with the proton translocation at complexes III and IV, a proton gradient is formed which is used by complex V, an ATP synthase, to generate ATP from ADP and inorganic phosphate. The redox action of CI can be summarized in the following overall reaction scheme [1, 2] :
How electron transfer is coupled to proton translocation is subject to debate [3, 4] . It could be directly coupled via close proximity of the ubiquinone binding site to proton translocation, or indirectly via conformational changes of the enzyme complex. Recent data obtained for bacterial and Yarrowia lipolytica CI provide support for the latter option [5] [6] [7] [8] [9] . In addition, CI is observed to undergo slow active/de-active transitions in a range of eukaryotes depending on temperature, pH and the presence of bivalent cations [10] [11] [12] [13] [14] .
Complex I structure
Complex I is L-shaped, consisting of two perpendicular arms: a hydrophobic membrane arm which resides in the mitochondrial inner membrane and a hydrophilic peripheral or matrix arm which protrudes into the mitochondrial matrix [15] [16] [17] (see Fig. 1 ). Three-dimensional electron microscopy of Y. lipolytica CI recently demonstrated detailed contours and protrusions of the complex, underlining that CI is a complicated and possibly highly dynamic structure [18] . At a higher resolution, the crystal structure of the peripheral arm of Thermus thermophylus CI recently elucidated the exact arrangement of the iron-sulfur clusters within the complex [8, 19, 20] . Bacterial CI consists of the 14 most conserved subunits and is considered to be the 'mimimal' structure required for functionality of the enzyme. A typical example of bacterial CI is Escherichia coli NDH-1 [22, 23] . By analogy to its core structure, three functional modules can be distinguished for human CI. The first is the dehydrogenase module, which is responsible for the oxidation of NADH and consists of at least the NDUFV2, NDUFV1 and NDUFS1 subunits (homologues of the nuoE, F and G subunits of bacterial NDH-1) (see Table 1 for an overview). The second is the hydrogenase module, which guides the released electrons to electron acceptor ubiquinone and consists of at least the NDUFS2, NDUFS3, NDUFS7 and NDUFS8 subunits (homologues of the nuoD, C, B and I subunits of NDH-1). Finally, the third is the proton translocation or transporter module, which consists of at least the ND1, ND2, ND3, ND4, ND4L, ND5 and ND6 subunits (homologues of the nuoH, N, A, M, K, L and J subunits of NDH-1).
Currently, 45 subunits have been described for human CI, an addition of 31 supernumerary subunits to the functional "core" structure of 14 subunits. Their topology was inferred by fractionation of bovine CI using chaotropic salts and the detergent N, N-dimethyldodecylamine N-oxide [24] [25] [26] (see Fig. 1 ). The function of most of the supernumerary subunits is yet unclear. They are hypothesized to stabilize or to protect the complex from damage inflicted by reactive oxygen species (ROS). Furthermore, at least several of these subunits may have an additional function.
One such a function is in apoptosis. For example, the NDUFA13 (GRIM-19, or Gene associated with Retinoid-IFN induced Mortality in bovine CI) subunit is also a cell death regulatory protein induced by interferon-beta and retinoic acid and was demonstrated to be released from the mitochondrion upon apoptosis [27] [28] [29] . Recently, GRIM-19 was shown to associate with the pro-apoptotic serine protease HtrA2 to promote cell death [30] . An apoptotic function is also described for subunit NDUFS1, as caspase mediated cleavage of this subunit is a requirement for the mitochondrial changes associated with apoptosis [31] .
Another is a function in fatty acid biosynthesis. The Neurospora crassa and bovine SDAP subunits (homologues of the human NDUFAB1 subunit) are closely related to the acylcarrier proteins involved in bacterial fatty acid biosynthesis [32] [33] [34] [35] . Interestingly, disruption of the gene in N. crassa resulted in a 4-fold increase in the amount of lysophospholipids in the mitochondrial membranes, suggestive of a function for this subunit in lysophospholipid recycling [36, 37] . Whether the N. crassa situation also applies to other organisms is subject to debate, as recent studies for bovine heart and Arabidopsis thaliana mitochondria show that most of the of mitochondrial acyl-carrier protein is present in the mitochondrial matrix and not associated to CI [35, 38] .
For several other subunits some features are known, but the exact additional function is yet unclear. The NDUFA9 subunit is known to harbour a NADH/NADPH binding site [39] [40] [41] [42] . The importance of this binding site for CI stability was recently demonstrated by mutagenesis of the Y. lipolytica homologue, which resulted in CI destabilization, presumably by destabilization of the structural fold of the subunit [43] . Fig. 1 . CI subunit topology (adapted from [21] ). CI is an L-shaped enzyme complex that can be dissected into several fragments, Iα, Iβ, Ik, and Iγ. The composition of these fragments allows a basic arrangement of the 45 subunits that comprise CI. The NDUFS4 subunit was described to be phosphorylated by a cAMP-dependent protein kinase (PKA), possibly indicating a function in regulation of CI activity [44] [45] [46] . However, this later proved to be the ESSS subunit (NDUFB11 in humans) [47] . Additional studies demonstrated phosphorylation of the bovine homologues of the NDUFC2, NDUFA1, NDUFA7, NDUFA10 and GRIM-19 subunits [47] [48] [49] [50] . Based on the phylogenetic distribution of different CI subunit orthologs, the NDUFA2 and NDUFA10 subunits were shown to belong to a family of proteins including the mitochondrial ribosomal proteins L43 and S25, respectively [51] . Finally, the NDUFA11 subunit was found to be paralogous to the TIM17/22 family of proteins [51, 52] .
Complex I assembly
Homology searches have revealed a high degree of conservation of certain modules of the complex between various organisms. Archaeal, cyanobacterial, bacterial and mammalian CI share great structural resemblance, although the electron input device (NADH dehydrogenase in mammalian CI) varies. Such phylogenetic studies have led to models describing the modular evolution of CI [22, [53] [54] [55] [56] [57] . In these models, CI is proposed to have originated by fusion of pre-existing protein assemblies constituting modules for electron transfer and proton transport. In more detail, CI is proposed to have originated from an ancestral soluble nickel-iron hydrogenase (sharing homology with the NDUFS2 and NDUFS7 subunits). This hydrogenase has gained a quinone binding site and has become membrane bound upon acquisition of a protein of unknown function (NDUFS3) and ferrodoxin-type (NDUFS8), ion translocating (ND5) and quinone-binding (ND1) subunits. This structure was subsequently expanded by triplication of proton translocating subunits (ND2 and ND4). After the complex has lost its nickel-iron active site and its ability to react with molecular hydrogen, finally, membrane subunits (ND3, ND4L and ND6) and the NADH dehydrogenase module (NDUFS1, NDUFV1 and NDUFV2) are acquired.
It has been suggested that the co-evolutionary structural relationship between CI subunits may be reflected by the order of assembly and composition of assembly intermediates [58, 59] . If so, how does the current model for human CI assembly relate to assembly studies performed in other organisms? If co-evolution of groups of subunits is partially mirrored by the human assembly system, would one not expect to see similarities in other organisms? Can a general assembly mechanism be extracted from these studies?
A useful starting point for the comparison between CI assembly mechanisms in different organisms is the structure of bacterial CI (NDH-1) [22] (Fig. 2A) . The underlying assumption is that the basic framework for the CI assembly process in all organisms is represented by the combination of its most conserved structural components. Through the years, the assembly process of CI has been investigated either indirectly in mutants or directly using conditional assembly systems, in various organisms such as bacteria (E. coli, Paracoccus denitrificans), the green alga Chlamydomonas reinhardtii, the fungus N. crassa, higher plants (Zea mays, Nicotiana sylvestris, A. thaliana) and mammals (Cricetulus griseus, Homo sapiens). Fig. 2B summarizes the assembly models proposed for these organisms, simplified by only showing assembly of the 14 'minimal' CI subunits. Details of each assembly scheme are given below, always referring to the NDH-1 homologue of each subunit.
Complex I assembly in bacteria
In E. coli CI assembly, incorporation of the NuoE, F and G subunits (forming the NADH dehydrogenase module) requires the presence of NuoB, C and D (forming the hydrogenase module) [60] . It is yet unclear whether this combination takes place before or after the addition of membrane arm subunits. Regarding membrane arm assembly, certain point mutations in the NuoH subunit of E. coli and P. denitrificans CI result in severely disturbed assembly [61] . In addition, disruption of the NuoJ gene did not result in disturbed assembly, suggesting that this membrane subunit is added to the complex at a final stage [62] . Finally, the distal location of the NuoM and NuoL subunits makes it likely that these subunits are added at a late stage in assembly [9, 63, 64] .
Complex I assembly in C. reinhardtii
Another organism in which CI assembly has been studied is C. reinhardtii. In this organism, frameshift mutations for ND1/ ND6 resulted in a failure to detect the 950-kDa holo-CI [65, 66] . Using the same strategy, absence of ND4 or ND4/5 resulted in accumulation of a 700-kDa subcomplex. Consequently, it was proposed that, as opposed to the ND1 and ND6 subunits, the ND4 and ND5 subunits (NuoM and L homologues) are incorporated at a late stage in assembly [67] . Recent investigation of the role of ND3 and ND4L (NuoA and K homologues) in assembly resulted in the first assembly model for this organism, in which a nuclear encoded precomplex of 200 kDa, containing the 76-kDa (NuoG homologue) and 49 kDa (NuoD homologue) subunits, is membrane anchored by combining with ND1 (NuoH homologue), ND3, ND4L and ND6 (NuoJ homologue) and subsequently expanded to result in holo-CI with the addition of ND4 and ND5 [67] . 
Complex I assembly in N. crassa
Complex I assembly in the fungus N. crassa has been thoroughly studied by systematic introduction of mutations in CI genes (for extensive reviews see [41, 58, [68] [69] [70] [71] ). In this organism, peripheral and membrane assembly intermediates are formed independently [72] . In turn, the membrane arm of N. crassa CI is assembled from a large and small intermediate [41, 58, [68] [69] [70] [71] . The small intermediate contains the ND2 and ND5 subunits (NuoN and NuoL homologues), whereas the large intermediate contains ND1, 3, 4, 4L and 6 (NuoH, A, M, K and J homologues) [58, 73] . Generally, mutations in subunits of the one arm do not adversely affect the assembly of the other [72, 74, 75] . Exceptions to this rule are loss of the acyl carrier protein (NDUFAB1 or SDAP homologue), which disturbs formation of both peripheral and membrane arms, and loss of the 11.5-kDa protein (NDUFS5 homologue), which results in accumulation of membrane arm intermediates and failure to detect an active peripheral arm [36, 37, 76] . Altogether, these studies have resulted in one of the first models of CI assembly in a eukaryote [41, 69] .
Complex I assembly in higher plants
Insights into the assembly of higher plant mitochondrial CI were mostly provided with mutant studies in maize (Z. mays), tobacco (N. sylvestris) and Arabidopsis (A. thaliana). In addition to NAD1-6 and NAD4L, the plant mitochondrial genome encodes NAD7 and NAD9, which are homologues of the NuoD (NDUFS2) and NuoC (NDUFS3) subunits, respectively [77] . In the maize NCS2 (nonchromosomal stripe 2) mutant, the nad4 and nad7 genes are fused and the nad4 gene lacks the fourth exon resulting in severe impairment of CI activity [78] . Bluenative analysis demonstrated the occurrence of a loosely membrane bound subcomplex, which displays in-gel activity and contains at least peripheral arm subunits 51 kDa (NuoF homologue), 75 kDa (NuoG homologue), 40 kDa (NDUFA9 homologue), NAD7 and NAD9 [79] . In addition, proteins with sizes of membrane arm subunits NAD1, 2, 3, 4 and 4L were not detected. Therefore, it seems that absence of NAD4 (NuoM homologue) results in the assembly of a loosely membrane bound peripheral arm of CI. The tobacco mutant NMS1 displays a splicing defect of the first nad4 intron [80] . Although mitochondrial genes are unaffected and transcription seems normal (except for nad4), numerous polypeptides (NAD7, NAD9, 23 kDa (NuoI) and 38 kDa (NDUFA9) subunits) are present only in trace amounts, demonstrating the importance of NAD4 for the stability of these proteins. Immuno-purification of CI resulted in a near-completely assembled CI, albeit in only 1-20% of the wild-type amount. This subcomplex contains at least NAD7 and NAD9, in line with what was found for the maize NCS2 mutant. In the tobacco CMSI and CMSII (cytoplasmic male sterile I and II) mutants, the NAD7 subunit is absent due to a large mitochondrial deletion including the last two exons of the nad7 gene (and the upstream region of nad1) [81] [82] [83] . CMSI and CMSII mutants display similar alterations in phenotype. In the CMSII mutant, besides NAD7, also mitochondrial subunits NAD1 (NuoH homologue), NAD9 and nuclear DNA-encoded subunits 23 kDa (NuoI) and 38 kDa (NDUFA9) are missing or present in very low amounts [83] [84] [85] . NAD9-purification in the CMSII mutant did demonstrate low abundant (10%) presence of NAD9. As transcription of NAD9 is unaffected, this suggests that the nonintegrated subunit is subject to proteolysis. This does not seem to occur for NAD2 (NuoN homologue) and NAD3 (NuoA homologue), which contrary to NAD1 were detectable in the mutant [83] . Complementation of the defect by nuclear expression of NAD7 in the CMSII mutant results in restoration of CI assembly [85] . It thus appears that NAD7 plays a key role in CI assembly in plants and seems to be directly involved in both peripheral and membrane arm assembly in tobacco. A final mutant concerns the Arabidopsis deletion mutant of the gamma carbonic anhydrase gene [86] . The anhydrase was demonstrated be present in purifications of CI [87, 88] as an integral membrane protein facing the matrix side part of the CI membrane arm [89] . Knockout of the protein reduces CI and CI/CIII supercomplex levels with about 80% [86] . The 20% remaining CI seems to be assembled without the anhydrase, suggesting a putative facilitating or stabilizing role during assembly. The exact function of the anhydrase is unclear and physiological evidence of its carbonic anhydrase activity could not be demonstrated, but a role in pH regulation is proposed [86] .
Complex I assembly in mammals
Although (bovine heart) CI stability, subunit composition and topology have been extensively studied using various methods to fractionate the complex, the assembly process of mammalian CI has long remained enigmatic [24, 25, 54, [90] [91] [92] [93] [94] [95] [96] . The use of compounds that inhibit either mitochondrial or nuclear translation and assembly studies in several rodent and human ND-subunit mutant cell lines have demonstrated that subassemblies of nuclear DNA-encoded CI subunits could be formed in the absence of mtDNA-encoded subunits [97] [98] [99] [100] . These findings had the important implication that CI subunits are not incorporated during assembly one by one (in a sequential manner), but that discrete assembly intermediates consisting of several subunits occur which are combined during assembly (in a semi-sequential manner). A useful model system for subsequent mammalian CI assembly studies proved to be C. griseus (Chinese hamster) [101] [102] [103] [104] [105] [106] . By using (inducible) complementation of the MWFE and ESSS subunits (homologues of the human CI NDUFA1 and NDUFB11 subunits) it was demonstrated that the stability of Chinese hamster homologues of peripheral arm subunits NDUFS1, 2, 3, 7, 8 and NDUFV1, 2 (NuoB, C, D, E, F, G, I homologues) was unaffected by the absence of MWFE, although holo-CI was not assembled. These data strongly suggest that the peripheral arm can be assembled without the presence of a membrane arm, analogous to assembly in N. crassa and in higher plants. Furthermore, incorporation of MWFE is proposed to require membrane arm subunits and the subunit may serve as a membrane anchor to which membrane subunits are attached during CI assembly. Likewise, the ESSS subunit was shown only to be incorporated into CI when membrane subunits are available [104] .
Complex I assembly in humans
Initial investigations for CI assembly in humans and other higher eukaryotes have mainly contributed data concerning the requirement of mtDNA-encoded subunits [107] . Immunoprecipitation studies in an ND4 cybrid cell line demonstrated that the membrane arm was not assembled when ND4 is disrupted [98] . Further investigations demonstrated that cells lacking either ND4 or ND5 display no in-gel CI activity, and immunoprecipitation of NDUFS3 revealed a subcomplex consisting of at least the NDUFS2, NDUFS3 and NDUFS8 subunits [108] . This shows that the absence of ND4 or ND5 still allows the formation of a peripheral arm subcomplex. Other studies underline the importance of ND5 for CI stability and/or activity rather than for assembly [99, 109] . The requirement of ND6 for assembly was demonstrated in a mouse ND6 frameshift mutant cell line [100] , later confirmed for human CI assembly in a CI deficient patient cell line carrying an ND6 mutation [110] . In addition, loss of ND3 does not lead to a great disturbance of assembly [111, 112] whereas ND2 disruption results in disturbed assembly with accumulated intermediates [113, 114] . Finally, ND1 mutation results in a severe reduction of fully assembled CI [115] .
Valuable information about the assembly of peripheral arm subunits has predominantly come from assembly studies in CI deficient patients. In 2001, Triepels and colleagues classified CI deficient patients by their assembly profiles by comparison of immunodetected amounts of CI subunits, suggesting an important role for subunits NDUFA9 and NDUFS3 [116] . In two patients harbouring a mutation in the NDUFS6 subunit, CI assembly was severely impaired and accumulation of a large 750 kDa subcomplex was observed using an anti-NDUFA9 antibody [111] . In addition, mutations in subunits NDUFS1, NDUFS4 and NDUFV1 lead to accumulation of a subcomplex slightly smaller than the fully assembled complex [117] [118] [119] [120] . Whether this subcomplex is the same in all of these studied cell lines is unclear, but the (near) absence of CI activity and the hypothesized co-localization in the tip of the peripheral arm of the complex support that their mutation may result in similar assembly/stability defects. Recently, Ogilvie and colleagues demonstrated association of assembly chaperone B17.2L with this complex and performed immunoprecipitation using an antibody raised against the B17.2L chaperone to identify associated proteins in wild type mitochondria [119] . Although the 830-kDa intermediate was not detected in wild type mitochondria, co-elution was observed of the ND1, NDUFS1-4, NDUFV1 and NDUFA13 subunits, suggesting the existence of (an) assembly intermediate(s) with this composition. Finally, of note, NDUFS8 mutation results in a severe impairment of CI assembly [118, 121] and two NDUFA1 mutations have been implicated in disturbed assembly and inability to detect a 20-kDa subunit (presumably the NDUFB8 subunit) in the holo-complex [122] .
An attempt to coherently incorporate the available assembly data into a model was first made in 2003, when Antonicka and colleagues published their human CI assembly model, based on the occurrence of CI subcomplexes in a cohort of CI deficient patients [113] . Different genetic defects resulting in CI deficiency can result in the accumulation of similar subcomplexes, which were argued to be illustrative of assembly intermediates. In the model, membrane and peripheral arm assembly does not occur independently as described for N. crassa but rather via membrane anchoring of preformed nuclear DNA-encoded scaffold of subunits. Peripheral subcomplexes consisting of NDUFS2, NDUFS3 and NDUFA9 are membrane anchored with the addition of at least ND1. Addition of another peripheral fragment containing at least NDUFS4, NDUFS7 and NDUFV2 precedes completion of the membrane arm and hence of holo-CI. This model provided a useful framework for future assembly studies, although the observed subcomplexes were derived from CI deficient patient cell lines and hence no distinction could be made between products of assembly, disturbed assembly, CI instability or degradation. In 2004, this study was followed by another based on a conditional assembly system [123] . In this system, the dynamics of assembly intermediate formation could be followed in time by removing a block in mitochondrial translation. It appeared that assembly occurs via combination and expansion of two parallel lines of assembly: that of the peripheral arm (via assembly of NDUFS2,3 and 4, NDUFA9 and NDUFV2) and that of the membrane arm (via assembly of at least ND1, ND6 and B17.2L). Although this system is artificial and nuclear DNA-encoded pre-assemblies may still have pre-formed, it allowed studying of the dynamics of subcomplex formation in time. In contrast to the 2003 study, it showed several similarities with the N. crassa model, in that membrane and peripheral arms could seemingly be assembled independently via distinct substructures.
In an additional study in 2007, NDUFS3 containing subcomplexes were made visible at high resolution using leakage expression of an inducible NDUFS3-GFP expression system in HEK293 cells. It confirmed several of the detected subcomplexes and demonstrated the presumable entry-point of mitochondrial DNA-encoded subunits into the assembly process [124] . In the proposed assembly model, the distinction between membrane and peripheral arm assembly was no longer as black and white as described in the previous study and for N. crassa. In fact, apart from the absence of NDUFA9 in early assembly intermediates, the model is generally similar to the 2003 study by Antonicka and colleagues. In both studies, an early peripheral arm assembly intermediate containing NDUFS2 and NDUFS3 is membrane anchored by ND1 prior to expansion with additional membrane arm and peripheral arm assembly modules. Recent confirmation of this sequence of events is provided by Lazarou and colleagues based on the incorporation of radiolabeled nuclear DNA-encoded CI subunits [125] . A peripheral precomplex containing NDUFS1, NDUFS2 and NDUFS7 is membrane anchored to a subcomplex containing membrane arm subunits. It is yet unclear exactly which ND subunits are part of the membrane anchor to which the preformed peripheral arm fragment is attached. A smaller subcomplex containing at least contain ND1 is detected, to which ND2, 3 and 6 are presumably added. Upon assembly of both peripheral and membrane intermediates, the structure is expanded with membrane arm subunits NDUFA9, NDUFA10 and NDUFB8 and the dehydrogenase part is added with subunits NDUFV1,2,3, NDUFS4 and NDUFS6.
To summarize, four models have been described for human CI assembly [113, [123] [124] [125] . Although different at points, the models agree in that a peripheral arm scaffold containing at least subunits NDUFS2 and NDUFS3 is anchored to the membrane by at least subunit ND1 prior to addition of remaining membrane subunits and remaining hydrogenase and NADH dehydrogenase module subunits (Fig. 3) . In Fig. 3 , the depicted 400/ 500 kDa membrane bound intermediates most likely also contain subunits NDUFS1, NDUFS7 and NDUFS8, and may also contain subunits ND2, ND3 and ND6. Added to the 800/ 850 kDa intermediate most likely are also NDUFV1, NDUFV3 and NDUFS6. However, the exact allocation of these subunits differs between the models, and for clarity purposes only the subcomplexes and subunits are shown which consistently appear at the same stages.
A general concept for complex I assembly
It is clear that there are differences between the various models. The investigated organisms are part of different evolutionary lineages and assembly of either the membrane or peripheral CI arm has been studied more extensively in the one organism than in the other. Furthermore, methods to detect membrane arm hydrophobic subunits employed so far are not sufficient, and the rate of proteolysis (owing to specific proteases in various organisms) or the kinetics of assembly/disassembly of individual subcomplexes in different organisms may not be the same.
Nevertheless, a general concept can be extracted (Fig. 2C) . In this generalized model, a nuclear scaffold containing at least the NuoC and NuoD subunits forms the starting point of peripheral arm assembly. Addition of NuoB, I, E, F and G results in a large peripheral arm subcomplex, which is anchored to the mitochondrial inner membrane via several of its transporter subunits (at least NuoH). Subsequently, this membrane anchored peripheral complex is expanded with additional membrane subunits to result in holo-CI. This simple model is basically compatible with theoretical data predicting subunit topology by evolutionary conservation except in that the NuoE, F and G subunits are not incorporated at the final stage of assembly.
The detailed human CI assembly pathway shown in Fig. 3 is basically similar to the consensus model for assembly in other organisms in Fig. 2C in the sense that a nuclear DNA-encoded scaffold is attached to the membrane prior to further expansion. Contrastingly, in the human CI assembly model, at least several subunits of the NADH dehydrogenase module are added at a final stage of assembly. This makes the human model even more compatible with the modular evolution scheme than the consensus model for other organisms.
Complex I assembly, future challenges
Altogether, these studies have set the basic outline of CI assembly, but unfortunately, aspects such as kinetics, turnover and stoichiometry were left mostly uninvestigated. The most recent assembly studies support that assembly is not necessarily a static process in which subassemblies are sequentially combined, but rather a dynamic process in which subunits or subcomplexes may be recycled during assembly. For example, the origin of one early assembly intermediate is rather enigmatic, as it appears both after breakdown and during assembly (subcomplex 1, [124] ). In addition, two subcomplexes containing at least subunits NDUFS2 and NDUFS3 appear in an equal ratio during assembly, suggesting that the formation of these subcomplexes is tightly linked (subcomplexes 2 and 3, [124] ). Recently, Lazarou and colleagues demonstrated that radiolabeled nuclear DNA-encoded subunits of CI are incorporated into CI much faster than mtDNA-encoded subunits [125] , confirmative of what was observed for rat hepatoma cell lines by Hall and Hare in 1990 [97] . Interestingly, none of the radiolabeled nuclear DNA-encoded CI subunits seemed limiting for assembly, which led to the proposal that newly synthesized nuclear DNA-encoded subunits may be exchanged with existing (incorporated) subunits. The possibility of subunit exchange during assembly is an interesting subject for future assembly studies, in which turnover rates of subunits and kinetics of the assembly process should be investigated.
The latter study addressed another interesting topic: does the formation of individual OXPHOS complex occur prior to supercomplex formation or not? Supercomplexes are combinations of OXPHOS complexes I, III and IV, observed after mild purification of mitochondrial inner membrane proteins [126] [127] [128] [129] [130] . Lazarou and colleagues demonstrated that assembly chaperone B17.2L associates to an 830-kDa intermediate of CI and to a combination of this intermediate with a complex III dimer [125] . B17.2L is then released from this partially assembled supercomplex intermediate, allowing CI assembly to be completed. Although this demands further experimentation, the possibility that supercomplex assembly occurs in conjunction with assembly of the individual OXPHOS complexes is very interesting. It may help in explaining Fig. 3 . Generalized model for human complex I assembly. A basic assembly scheme is constructed based on existing models for human CI assembly [113, [123] [124] [125] . Subunits and subcomplex sizes are denoted only when consistently observed throughout the studies. For details see text.
why the stability of one complex in the supercomplex depends on the stability of the other and subsequently how instability of one OXPHOS complex leads a combined OXPHOS deficiency [131] [132] [133] [134] [135] .
Although several assembly intermediates were observed for nuclear-DNA encoded subunits during human CI assembly, clear small and large membrane arm subcomplexes such as those found in N. crassa have not yet been demonstrated. Nevertheless, several studies report the existence of subcomplexes containing multiple ND subunits [125, 136] . Further investigation of these and other membrane arm intermediates is required for confirmation and characterization of the key step in which a preformed nuclear DNA-encoded subassembly is anchored to the mitochondrial inner membrane. This step may occur co-translationally, e.g. like CIV in yeast mitochondria. A search for factors such as the yeast Oxa1 and Mba1 that link mitochondrial translation to the membrane insertion of mtDNA-encoded CI subunits is a promising endeavor [137, 138] . In addition, one can imagine that both iron-sulfur cluster containing preformed subassemblies and hydrophobic membrane subassemblies would require chaperones for stabilization and combination without aggregation or production of radical species. An ongoing search for these chaperones is required for a better understanding of the assembly process.
Coordination of the assembly process
To assemble a fully functional human mitochondrial CI is to combine 38 subunits encoded by the nuclear genome and seven subunits encoded by the mitochondrial genome. In addition to just the combination of these subunits, it encompasses nuclear and mitochondrial transcription, translation, processing, export, import, membrane insertion, stabilization and activation, including numerous feedback mechanisms required to coordinate the process. When viewed from this perspective, the requirement of chaperone proteins for coordination of the CI assembly process becomes evident.
The classical definition of a chaperone
What exactly is a chaperone? Chaperones were first discovered when several genes, conserved from bacteria to mammals, were found activated upon transient heat stress in Drosophila, encoding the later termed heat-shock proteins (HSPs) [139, 140] . Later, a solid ground for the definition of chaperone function was provided with the demonstration that BiP, a protein interacting with proteins transiting through the ER prior to their assembly into macromolecular structures, is also a member of the HSP70 family [141, 142] (for a review see [143] ). In general, a chaperone is any protein that binds to an unfolded or partially folded target protein to prevent misfolding, aggregation, and/or degradation of it. Chaperones also facilitate the target protein's proper folding. A more detailed definition was proposed by John Ellis: molecular chaperones are currently defined in functional terms as a class of unrelated families of protein that assist the correct noncovalent assembly of other polypeptide-containing structures in vivo, but which are not components of these assembled structures when they are performing their normal biological functions. The term assembly in this definition embraces not only the folding of newly synthesized polypeptides and any association into oligomers that may occur, but also includes any changes in the degree of either folding or association that may take place when proteins carry out their functions, are transported across membranes, or are repaired or destroyed after stresses such as heat shock [144] [145] [146] [147] .
Human CI chaperones
In 1998, Kuffner and colleagues used essentially the same definition [146] to term Complex I Intermediate Associated proteins CIA30 and CIA84 chaperones for N. crassa CI assembly [73] . Disruption of the 21.3-kDa nuclear DNA-encoded subunit (homologue of the human NDUFS8 subunit) resulted in accumulation of a large membrane arm intermediate, to which CIA30 and CIA84 were found associated. Metabolic labeling experiments demonstrated that CIA84 cycles between a bound and unbound state to this intermediate. Additionally, knockout of the cia genes resulted in a membrane arm subunit knockout phenotype. In conclusion, the authors stated that the CIA proteins are involved in the assembly of the larger complex without being a component of the final functional structure, hence fitting the definition of chaperone [73] .
Both human orthologues of the CIA proteins have been found. CIA84 orthologue PTCD1 was identified in a bioinformatics screen, but its function in human CI assembly remains uninvestigated [51] . CIA30 orthologue NDUFAF1 was found in humans in 2002 and, in line with what is described for N. crassa, has an important role in human CI assembly [148] . Its knockdown using RNA interference resulted in impaired CI assembly/stability [149] . NDUFAF1 associates to CI subunits NDUFB6, NDUFA6, NDUFA9, ND1, NDUFS3 and NDUFS7 [150] . In addition, immunoprecipitation of NDUFAF1 in the presence of radiolabeled mtDNA-encoded subunits revealed transient association to subunits ND1, ND2 and ND3. In the same paper, the first patient with a mutation in the NDUFAF1 gene was identified and demonstrated to be specifically CI deficient, a defect that was complemented by lentivirus transfection with the wild type protein. Taken together, these data strongly suggest that NDUFAF1 transiently associates to early intermediates of CI assembly to aid the assembly process. It is yet uncertain whether its function in CI assembly is represented by its association to the 500-850 kDa subcomplexes, as (near) absence of CI assembly does not eliminate the presence of NDUFAF1 in these complexes [151] .
A paralogue of CI subunit B17.2, termed B17.2-like (B17.2L), was predicted and confirmed to be a chaperone for human CI assembly in 2005 [51, 119] . In line with the above description of a chaperone it is required for CI assembly but not part of the final structure. The protein is visible in a subcomplex of about 830 kDa, especially upon mutation of the NDUFV1 or NDUFS4 subunits of CI, but also in low amounts in control skin fibroblasts as demonstrated by incorporation of radiolabeled B17.2L [125] . With the use of immunoprecipitation, B17.2L was found associated to CI subunits ND1, NDUFS2, NDUFS3, NDUFV1, NDUFV2, NDUFS4 and GRIM-19 [119] .
The most recently identified protein demonstrated to be essential for CI assembly is Ecsit (Evolutionarily Conserved Signaling Intermediate in Toll pathways) [152] . Ecsit is predominantly cytosolic, but a small amount is recruited to the mitochondrion via its N-terminal targeting sequence. Once imported, this mitochondrial Ecsit is incorporated into the same three high-molecular weight chaperone complexes of 500-850 kDa as NDUFAF1. Although only a relatively small amount is mitochondrial, as demonstrated by siRNA knockdown, Ecsit is required for stable mitochondrial presence of NDUFAF1, CI assembly/stability and normal mitochondrial physiology [152] . Hence, being required for CI assembly but not a component of the final functional structure, also Ecsit fits the definition of a chaperone.
Complex I assembly chaperones, versatile proteins
Only a few chaperones found for an approximately 1 MDa enzyme complex is a rather meagre score. By analogy to the other OXPHOS complexes, many more must surely exist, but why have they not been detected? One obvious answer is that the Saccharomyces cerevisiae toolbox of genetics that has proven so fruitful for studying e.g. CIV assembly is not available for CI, as it does not have CI. Secondly, many yet undiscovered chaperones that can associate to CI assembly intermediates (such as B17.2L) may not be detectable in their high-molecular weight associations under normal circumstances as their binding is transient. For example, the CIA proteins in N. crassa were only found after introduction of a mutation that resulted in accumulation of a large membrane arm assembly intermediate [73] . Finally, chaperones may function in additional processes rather than being confined to a function in CI assembly, which makes them harder to find from a CI-limited perspective.
That assembly chaperones may have functions additional to their requirement for CI assembly is in line with the growing awareness that mitochondria are more than just a powerhouse that provides ATP: they are plastic organelles, entangled with various (sub) cellular processes such as the cell cycle, apoptosis and development, via signaling cascades that include kinases and phosphatases that ultimately regulate mitochondrial metabolic activity [153] .
One example of such functional versatility is provided with B17.2L. This protein was initially described as Mimitin, the socalled myc induced mitochondrial protein [154] . Its transcription was shown to be directly stimulated by c-myc and its levels were found elevated in esophageal squamous cell carcinoma (ESCC) tumors. As its suppression using RNA interference led to decreased cell proliferation in several tissue types, a role in c-myc mediated cell proliferation was proposed. It was shortly later that Ogilvie and colleagues described its requirement for human CI assembly [119] .
Another is Apoptosis Inducing Factor (AIF). Loss of this protein in mice results in specifically impaired CI assembly/ stability [155, 156] . The AIF protein is known as a signaling molecule in apoptosis and has an N-terminal mitochondrial localization sequence. Upon apoptosis-induced mitochondrial outer membrane permeabilisation it translocates to the nucleus, chaperoned by HSP70. Once in the nucleus, it performs a role in chromatin condensation [157] . Loss of AIF leads to increased ROS production and AIF knockdown desensitizes different cell types to different apoptotic stimulants. In addition to this role in apoptosis, AIF knockout results in a drop in the mouse homologues of CI subunits NDUFA9, NDUFB6, NDUFS7 and GRIM19, CI activity and embryonic lethality, demonstrating its requirement for CI integrity [155] . Whether the effect of AIF is confined to OXPHOS complex CI alone is debated, as its S. cerevisiae homologue knockout exhibit reduced growth on nonfermentable carbon sources, and siRNA for AIF additionally resulted in a slight CIII defect. Whichever the exact mechanism, a protein such as AIF shows that a protein can be a signaling molecule in apoptosis and be specifically required for CI assembly or stability. Such chaperones may represent signaling nodes between various subcellular processes and the assembly of the OXPHOS system.
A promising final example is the Ecsit protein [152] . This signaling protein in the (cytosolic) Toll-pathway mediates communication between ligand binding at the plasma membrane to activation of transcription of pro-inflammatory genes [158, 159] . The dual function of this protein in both mitochondrial CI assembly and (cytosolic) immunity is intriguing. Although yet speculative, Ecsit may extend the cascade of the immune response to the inner-mitochondrial level, e.g. to control the amount of ATP production or to induce apoptosis upon inflammation.
Closing remarks
Fed by recent discoveries, CI assembly is no longer seen as an obligate-unidirectional pathway but rather as a highly dynamic process with multiple entry-points in which existing and newly synthesized subunits can be exchanged. Furthermore, there is increasing support for the idea that a fully assembled and stable CI is a key player in various immune and apoptotic pathways. Characterization of existing and novel chaperones and regulatory proteins may reveal additional connections between CI assembly/stability and mitochondrial and cellular function, with which CI assembly studies have gained a new and exciting dimension. Altogether, CI assembly not only proves to be a dynamic but also a versatile process. Hopefully, new insights into the process will aid the understanding of the broad spectrum of clinical phenotypes associated with mitochondrial disorders.
